Validating a biosignature-predicting placebo pill response in chronic pain in the settings of a randomized controlled trial

安慰剂 医学 慢性疼痛 随机对照试验 安慰剂反应 止痛药 麻醉 内科学 物理疗法 病理 替代医学
作者
Étienne Vachon‐Presseau,Taha Abdullah,Sara Berger,L. Q. Huang,James W. Griffith,Thomas J. Schnitzer,A. Vania Apkarian
出处
期刊:Pain [Lippincott Williams & Wilkins]
卷期号:163 (5): 910-922 被引量:10
标识
DOI:10.1097/j.pain.0000000000002450
摘要

Abstract The objective of this study is to validate a placebo pill response predictive model—a biosignature —that classifies chronic pain patients into placebo responders ( predicted-PTxResp ) and nonresponders ( predicted-PTxNonR ) and test whether it can dissociate placebo and active treatment responses. The model, based on psychological and brain functional connectivity, was derived in our previous study and blindly applied to current trial participants. Ninety-four chronic low back pain (CLBP) patients were classified into predicted-PTxResp or predicted-PTxNonR and randomized into no treatment, placebo treatment, or naproxen treatment. To monitor analgesia, back pain intensity was collected twice a day: 3 weeks baseline, 6 weeks of treatment, and 3 weeks of washout. Eighty-nine CLBP patients were included in the intent-to-treat analyses and 77 CLBP patients in the per-protocol analyses. Both analyses showed similar results. At the group level, the predictive model performed remarkably well, dissociating the separate effect sizes of pure placebo response and pure active treatment response and demonstrating that these effects interacted additively. Pain relief was about 15% stronger in the predicted-PTxResp compared with the predicted-PTxNonR receiving either placebo or naproxen, and the predicted-PTxNonR successfully isolated the active drug effect. At a single subject level, the biosignature better predicted placebo nonresponders, with poor accuracy. One component of the biosignature (dorsolateral prefrontal cortex–precentral gyrus functional connectivity) could be generalized across 3 placebo studies and in 2 different cohorts—CLBP and osteoarthritis pain patients. This study shows that a biosignature can predict placebo response at a group level in the setting of a randomized controlled trial.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英俊的铭应助头上长犄角采纳,获得10
刚刚
大模型应助健忘小霜采纳,获得10
刚刚
宁地啊完成签到 ,获得积分10
1秒前
你快睡吧发布了新的文献求助10
2秒前
隐形曼青应助平淡夜柳采纳,获得10
2秒前
lllwww完成签到,获得积分10
3秒前
JamesPei应助hmx采纳,获得10
4秒前
犹豫石头发布了新的文献求助10
4秒前
susu完成签到,获得积分10
5秒前
忧伤的尔白完成签到,获得积分10
6秒前
CipherSage应助勤恳的夏之采纳,获得10
6秒前
小二郎应助阿萨德采纳,获得10
6秒前
在水一方应助甘蔗侠采纳,获得10
7秒前
彭于晏应助linmo采纳,获得10
7秒前
landiao发布了新的文献求助10
10秒前
10秒前
清秋完成签到 ,获得积分10
11秒前
11秒前
12秒前
12秒前
13秒前
13秒前
14秒前
Rosie发布了新的文献求助10
16秒前
16秒前
LKL林完成签到,获得积分10
16秒前
16秒前
1111应助科研通管家采纳,获得10
17秒前
Akim应助科研通管家采纳,获得10
17秒前
17秒前
只A不B应助科研通管家采纳,获得10
17秒前
坦率的匪应助科研通管家采纳,获得10
17秒前
17秒前
李爱国应助科研通管家采纳,获得10
17秒前
田様应助科研通管家采纳,获得10
17秒前
ED应助科研通管家采纳,获得10
17秒前
1111应助科研通管家采纳,获得10
17秒前
18秒前
czh应助科研通管家采纳,获得10
18秒前
18秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988827
求助须知:如何正确求助?哪些是违规求助? 3531197
关于积分的说明 11252739
捐赠科研通 3269830
什么是DOI,文献DOI怎么找? 1804815
邀请新用户注册赠送积分活动 881915
科研通“疑难数据库(出版商)”最低求助积分说明 809028